Program Catalog

Neuropsychiatric Health

logo

wc Pharmacologic Management of Primary Generalized Tonic-Clonic Seizures (PGTC) and Partial-Onset Seizures (POS). Program Chair: Trevor Resnick, MD

wc The Evolving and Complex Therapeutic Landscape for Multiple Sclerosis.. Program Chairman: Douglas Jeffery, MD, PhD.

wc New and Evolving Therapies in Multiple Sclerosis— The Managed Care Perspective. Program Chairman: Bruce Cree, MD.

wc The Emerging Challenges on the Therapeutic Landscape of Multiple Sclerosis:The Managed Care Perspective—New York, NY. Program Chairman: Bruce Cree, MD.

wc Emerging Challenges on the Therapeutic Landscape of Multiple Sclerosis. Program Chairman: Bruce Cree, MD. New York, NY.

wc The Evolving and Complex Therapeutic Landscape for Multiple Sclerosis. Program Chairman: Douglas Jeffery, MD. Atlanta, GA.

wc Optimizing Neurotherapy and Emerging Paradigms in Alzheimer’s Disease. Program Chairman: Murray A. Raskind, MD. International Congress

wc The Evolving Therapeutic Landscape for Multiple Sclerosis. Program Chair: Bruce A. Cree, MD.

wc New Frontiers in Neurotherapy for Multiple Sclerosis.Program Chair: Bruce A. Cree, MD.

wc The Science and Medicine of Hypoactive Sexual Desire Disorder (HSDD).
Program Chair: Anita H. Clayton, MD.

National Congress

wc Under primary care and Neuropsych.
Optimizing Neurotherapy for Multiple Sclerosis and Parkinson’s Disease
Program Chair: C. Warren Olanow, MD.

wc iQ&A interactive Medical Intelligence Zone for Adolescent Depression.
International Experts’ Forum.

wc The Science and Medicine of Parkinson’s Disease.Program Chairman: Robert A. Hauser, MD

wc The Science and Medicine of Multiple Sclerosis.Program Chairman: Jerry S. Wolinsky, MD.

wc The Science and Medicine of Parkinson’s Disease. Program Chairman: Lawrence W. Elmer, MD, PhD.

wc Critical Challenges in Neuropsychiatric Health: Depression, Anxiety and Dementia;
Program Chairman: Mark Pollack, MD
 

wc Critical Challenges in Alzheimer’s Dementia: A Global Approach for Optimizing Patient Care; Program Chairman, Steven G. Potkin, MD

wc Alzheimer’s Dementia: A Primary Care Perspective—Applying Landmark Trials & Evidence-Based National Guidelines to Primary Care and Geriatric Practice; Program Faculty: Joseph L. Micca, MD, Joseph Gruber, RPh, CGP, FASCP, Joshua R. Shua-Haim, MD, Steven G. Potkin, MD

wc Preventing Stroke and Heart Disease: Applying Evidence to the Front Lines of Practice: Focus on Hypertension and Lipid-Lowering Agents Across the Cardiovascular Disease and Stroke Risk Spectrum; Program Chairman: Paul M. Ridker, MD

MedicineWRAPs—A Leading Investigator, First Person Clinical Report

mm MultipleSclerosisWRAP: A Leading Investigator, First Person Clinical Report. Immunomodulation Therapy for MS.Presenter: Bruce A. Cree, MD.

mm MultipleSclerosisWRAP: A Leading Investigator, First Person Clinical Report. Evolution of Neurotherapeutic Agent for MS.Presenter: Douglas R. Jeffery, MD, PhD.

mm Alzheimer’sWRAP: A Leading Investigator, First Person Clinical Report. The Foundation Role of Cholinergic Dysregulation in AD
Presenter: Jeffrey L. Cummings, MD

mm Parkinson’sWRAP: A Leading Investigator, First Person Clinical Report. Landmark Advances in Parkinson’s Disease. Presenter: C. Warren Olanow, MD, FRCPC.

mm MultipleSclerosisWRAP—A Leading Investigator, First Person Clinical Report. Optimizing Clinical Outcomes in MS. Presenter: Patricia Coyle, MD.

mm MultipleSclerosisWRAP—Focus on Disease Classification, Natural History and Long-Term Outcomes.
Presenter: Jerry S. Wolinsky, MD.

mm FibromyalgiaWRAP: Focus on Diagnosis, Assessment, and Pharmacologic Management. Presenter: Don L. Goldenberg, MD.

mm FibromyalgiaWRAP—Optimizing Management of Fibromyalgia: A Systematic Approach to Pharmacotherapy. Presenter: Robert Bennett, MD.

mm Alzheimer’sWRAP—A Leading Investigator, First Person Clinical Report: The Current and Future Role of Neuroimaging in Patients with Dementia; Presenter: Steven G. Potkin, MD  

mm DementiaWRAP: Multimodal Management in the Long-Term Care (LTC) Setting; Presenter, Joseph L. Micca, MD

mm PsychiatryWRAP: Screen and Intervene—Critical Challenges in Alzheimer's Dementia; Presenter, George T. Grossberg, MD

mm Alzheimer’sWRAP: Critical Challenges in Behavioral Management—Pearls for the Front Lines of Clinical Practice; Presenter:Kevin Franklin Gray, MD

mm GeroPsychiatryWRAP: Optimizing Pharmacologic and Nonpharmacologic Management of Dementia in The Assisted Living and Nursing Home Setting; Presenter, Elaine R. Peskind, MD

mm Alzheimer’sWRAP: Diagnosis, Staging, and Outcome-Effective Drug Therapy: An Evidence-Based Perspective; Presenter, Jeffrey L. Cummings, MD

Cardiovascular Medicine

Science to Strategy Summits

wc New Frontiers and Emerging Therapeutic Paradigms in Comprehensive Thrombosis Management.
Program Co-Chairs: Samuel Z. Goldhaber, MD and Christian T. Ruff, MD.

JUST LAUNCHED

wc Obesity Management in Patients with Type 2 Diabetes.
Program Chair: Vivian Fonseca, MD.

National Congress JUST LAUNCHED

wc iQ&A interactive Thrombosis Intelligence Zone: Principles and Practice of Comprehensive Thrombosis Management.
Program Co-Chairs: Professor the Lord Ajay Kakkar, MD, PhD, and Samuel Z. Goldhaber, MD.

JUST LAUNCHED

wc iQ&A interactive Medical Intelligence Zone for Iron Deficiency Anemia—IV Iron for Managing IDA.
JUST LAUNCHED

wc New Frontiers and Emerging Paradigms for LDL-Mediated Cardioprotection.
Program Chairman:
Deepak L. Bhatt, MD.

National Congress JUST LAUNCHED

wc Individualizing Obesity Management.
Program Co-Chairs: Kenneth J. Fujioka, MD and Lee Kaplan, MD.

National Congress JUST LAUNCHED

wc New Frontiers and Treatment Paradigms for Stroke Prevention in Atrial Fibrillation.
Program Chair: Samuel Z. Goldhaber, MD. International Congress.

National Congress

wc Optimizing Cardiovascular Outcomes in Type 2 Diabetes.
Program Chairs: Vivian A. Fonseca, MD and A. Michael Lincoff, MD.

National Congress

wc Optimizing Patient Outcomes in Type 2 Diabetes. Program
Chairmam: Vivian A. Fonseca, MD.

National Congress

wc iQ&A Medical Intelligence Zone for Management of Familial Hypercholesterolemia – Part II.

wc iQ&A Medical Intelligence Zone for Comprehensive Cardiovascular Risk Reduction in Type 2 Diabetes and ACS. Program Chairman: A. Michael Lincoff, MD  

wc Optimizing Management of Familial Hypercholesterolemia. Program Chairmen: Paul Ridker, MD and James McKenney, PharmD.
National Congress

wc Kidney-Mediated Glucose Homeostasis in Type 2 Diabetes. Program Chairman: Lawrence Leiter, MD. National Congress

wc Cardiovascular Risk Reduction in Patients with Type 2 Diabetes. Program Chairman: A. Michael Lincoff, MD. National Congress

wc Best Practice Guidelines for Insulin Use in Type 2 Diabetes. Program Chairman: Charles F. Schaefer, MD.

wc Insulin Therapy in Type 2 Diabetes. Program Presenter: Juan P. Frias, MD.

wc Optimizing Outcomes in Type 2 Diabetes. Program Chairman: Vivian A. Fonseca, MD.

wc iQ&A interactive Medical Intelligence Zone for Familial Hypercholesterolemia

wc Optimizing Outcomes in Type 2 Diabetes. Program Chairman: Vivian A. Fonseca, MD. National Congress

wc Stroke Prevention in Atrial Fibrillation. Program Chair:
Samuel Z. Goldhaber, MD.

National Congress

wc New Frontiers and Emerging Paradigms for Cardiovascular Risk Reduction in the Setting of Diabetes and ACS. Program Chairman:
A. Michael Lincoff, MD

National Congress

wc The Science and Application of Antithrombotic Interventions for High Risk ACS. Program Chairman:
Deepak L. Bhatt, MD.

National Congress

wc Cardiovascular Risk Reduction in the Setting of Type 2 Diabetes and ACS. Program Chairmen:
Gilles Montalescot, MD, PhD and Richard W. Nesto, MD.

International Congress

wc New Frontiers and Evolving Paradigms in Cancer and Thrombosis. Program Chairman: Professor the Lord Ajay Kakkar, (HONS) BSC, PhD, FRCS.
International Congress

wc Lake Breaking Advances in Stroke Prevention in Atrial Fibrillation. Program Chairman:
Samuel Z. Goldhaber, MD.

wc New Frontiers in Stroke Prevention in Atrial Fibrillation. Program Chairman:
Samuel Z. Goldhaber, MD.

wc Stroke Prevention in Atrial Fibrillation. Program Chairman:
Samuel Z. Goldhaber, MD.

National Congress.

wc New Frontiers and Evolving Paradigms in Cancer and Thrombosis.
Program Chairman:
Samuel Z. Goldhaber, MD.

National Congress.

wc iQ&A interactive Medical Intelligence Zone for Stroke Prevention in Atrial Fibrillation. Program Chairman: Samuel Z. Goldhaber, MD.

wc New Frontiers in Stroke Prevention for Atrial Fibrillation.
Program Chairman: Allan V. Abbott, MD.

National Congress.

wc iQ&A interactive Medical Intelligence Zone for VTE Prophylaxis.
Program Chairman: Samuel Z. Goldhaber, MD.
 

wc New Frontiers in Thrombosis Reduction for Heart Disease.
Program Chairman Deepak L. Bhatt, MD.
 International Congress

wc New Frontiers in the Science and Medicine of Venous Thromboembolism.
Program Chair: Samuel Z. Goldhaber, MD.
 International Congress

wc New Paradigms and Landscape Changes in Atrial Fibrillation.   Program Chairman: Peter Libby, MD, FACC.
National Congress

wc The iQ&A interactive Medical Intelligence Zone for Thrombosis Management.Program Chairman: Samuel Z. Goldhaber, MD

wc The iQ&A interactive Medical Intelligence Zone for DVT and PE.
Program Chairman: Samuel Z. Goldhaber, MD

wc The New Frontiers in Atrial Fibrillation  .Program Chairman: Samuel Z. Goldhaber, MD
National Congress

wc Clots, Contrast Media and Catheterization. Program Chair: Steven V. Manoukian, MD.
National Congress

wc Antiplatelet Therapy in the Catheterization Laboratory. Program Chairmen: Deepak L. Bhatt, MD, and Shamir Mehta, MD
National Congress

wc The Evolving and Foundation Role of LMWHs in Cancer and Thrombosis.
Program Chair: Craig M. Kessler, MD.

International Congress

wc Critical Advances in the Science
and Medicine of Thromboembolic Disease.   Program Chairs: Stavros V. Konstantinides, MD and John H. Alexander, MD.
International
Congress

wc The Science and Medicine of Cancer and Thrombosis Management.
Program Chair: Craig M. Kessler, MD.

International Congress

wc Supportive Care for the Cancer Patient. Program Chairmen: Craig M. Kessler, MD and Steven Grunberg, MD

wc Landmark Advances and Complex Cases in Cardiovascular Anesthesi-ology. Program Chairmen: Solomon Aronson, MD and Jerrold Levy, MD.National Congress

wc Optimal Strategies for Compre-hensive Target Organ Protection in Heart Disease and ypertension. Program Chairman: Matthew R. Weir, MD.
National Congress

wc Evolving Perspectives on the Role of Beta-Blockers Acros the Risk Spectrum for Heart Disease.
Program Chairman: Henry R. Black, MD.
National Congress

wc Critical Advances in the Evolving Science and Medicine of STEMI Management and High-Risk ACS Program Chairman: Sunil V. Rao.National Congress

wc Optimizing Outcomes in Patients
with STEMI and High-Risk ACS.
Rome, Italy.
International Congress

wc Management of STEMI and High Risk ACS. Program Chairman: Sunil V. Rao, MD National Congress

wc European Cardiovascular Experts’ STEMI (ECES) Summit. Zurich, Switzerland. International Summit

wc DVT Prophylaxis in the Cancer Patient. Program Co-Chairs: Edith Nutescu, PharmD, FCCP, and Samuel Z. Goldhaber, MD.
National Congress

wc International Cardiovascular Experts’ Roundtable— Focus on Mortality Reduction in STEMI
European Summit

wc Landmark Advances in High Risk Acute Coronary Syndrome Program Chairman: Charles V. Pollack, MD, FACEP.National Congress

wc Landmark Practice Advances in Acute Blood Pressure Management. Program Chairman: Charles V. Pollack, MD, FACEP. National Congress

wc VTE Prophylaxis in the Setting of Cancer.Program Chairman: Craig M. Kessler, MD.

wc New Dimensions and Landmark Practice Advances In Hypertension and Heart Disease. Program Chairman: Kenneth Jamerson, MD.

wc Landmark Practice Advances in STEMI and ACS: The European Perspective. Chairmen: Carlo Di Mario, MD, PhD, FESC, FACC, FRCP and Stefano Savonitto, MD, FESC.
European Congress

wc Landmark Advances in Cardiovascular Anesthesiology. Program Chairmen: Jerrold H. Levy, MD and Solomon Aronson, MD

wc Cancer and Thrombosis Management. Program Chairman: Charles W. Francis, MD
National Congress

wc Milestone Practice Advances in
STEMI and High Risk ACS.
Program Chairman: Sunil Rao, MD

wc The Science and Medicine of Acute Coronary Syndrome. Program Chairman: Sunil V. Rao, MD
National Congress

wc The Science and Medicine of Circulatory Dysfunction and Acute Pressure Syndromes. Program Chairman: Christopher B. Granger, MD

wc From Threat to Therapy: Vascular Dysfunction And Acute Pressure Syndrome. Program Chairman:
Joseph Varon, MD.

wc Critical Challenges and Landmark Advances in Vascular Interventional Management. Program Chairman: Deepak Bhatt, MD, FACC, FSCAI, FESC, FACPNational Congress

wc Critical Challenges in Acute Coronary Syndromes—The Road from REPLACE-2 to ACUITY and HORIZONS MI.   Program Chairman: E. Magnus Ohman, MD, FRCPI, FACC.National Congress

wc Vascular Dysfunction and Acute Pressure Syndromes. Program Chairman: Christopher B. Granger, MD
National Congress

wc Comprehensive Cardiovascular Protection— New Dimensions and Landmark Practice Advances
Program Chairman: Matthew R. Weir, MD.
National Congress

wc Acute Pressure Syndromes—From Threat to Therapy. Program Chairman: Charles V. Pollack, MD, FACEP  
National Congress

wc Cardiovascular Emergencies—New Dimensions and Critical Practice Advances Program Chairman: Charles V. Pollack, MD, FACEP National Congress

wc Optimizing Management of Hypertension and Cardiovascular Outcomes in the Black Patient—A Year 2007 ISHIB Satellite Symposium  Distinguished Faculty: Shawna Nesbitt, MD, Kenneth Jamerson, MD, Jackson Wright, MD, PhD National Congress

wc B1 Cardioselective Beta-Blockers— Current Thinking About Conventional vs. Emerging Agents: When? Why? In What Patients? Presenter: Michael Weber, MD

wc Acute Blood Pressure Elevation in the Perioperative Setting: Issues, Challenges, and Options: A Sanctioned CME Satellite at the Society for Cardiovascular Anesthesiology; Faculty: Solomon Aronson, MD, FACC and Jerrold Levy, MD (Co-Chairmen) and Kevin Stierer, MD.National Congress

wc Evolving Approaches to Antithrombotic Therapy in Patients with Acute Ischemic Heart Disease-Establishing Evidence-and Collaboration-Based ACS Management Protocols for Interventional Cardiologists and Emergency Medicine Specialists: A National and Regional EDICT for ACS Initiative, New York; Program Chairmen, Gregg Stone, MD, FACC and Charles V. Pollack, MD, FACEP

wc Critical Challenges in Cardiovascular Medicine: Establishing Interventional Cardiology and Emergency Medicine Therapeutic Teams (EDICT) for ACS; Program Chairman: Steven V. Manoukian, MD, FACC

wc Optimizing Clinical Strategies in Heart Disease: Linking Science and Expert Analysis to Advances in Hypertension— Focus on Cardioselective Beta-Blockers and Risk Factor Management; Program Chairman: Michael Weber, MD

wc Advancing Management of Acute Coronary Syndromes—A National Experts’ Science-to-Strategy Summit and Satellite Symposium; Program Chairman: Peter B. Berger, MD, FACC  National Congress

wc Hot Cases in ACS: Managing Patients with High Risk Acute Coronary Syndromes—National Experts Weigh in on Strategies and the Evidence; Program Chairman, A. Michael Lincoff, MD; Panel Members: Elliott Antmann, MD, Peter Berger, MD, Magnus Ohman, MD  National Congress

wc EDICT (Emergency Department and Interventional Cardiology Therapeutic teams) for ACS: Critical Challenges in Cardiovascular Medicine—Establishing Seamless Interventional Cardiology and Emergency Medicine Clinical Strategies ; 2007, Boston, MA., Program Chairmen: Michael Gibson, MD and Charles Pollack, MD. 

wc Advances in Hypertension, Heart Failure, and Global Risk Management in Heart Disease—The Current Role of Beta-Blockers; Program Chairman: Mark Dunlap, MD

wc Heart Disease and Stroke: Applying Evidence to the Front Lines of Practice: Focus on Lipid-Lowering Agents Across the Cardiovascular Disease and Stroke Risk Spectrum; Program Chairman: Paul M. Ridker, MD

wc Advancing The Management of Acute Coronary Syndromes (ACS)—The Emergency Medicine Perspective Program Chairman: Charles V. Pollack, MA, MD, FACEP, FAAEMNational Congress

wc Optimizing Net Clinical Benefit in PCI: Applying Late-Breaking Research in ACS Management to the Cardiac Catheterization Laboratory; Program Chairman: Jeffery J. Popma, MD, FSCANational Congress

wc ACS Management in the Emergency Department: Approaches to Dynamic Risk Assessment and Antithrombotic Therapy;
Program Chairman: Charles V. Pollack, MA, MD, FACEP, FAAEM   National Congress

wc Interventional Cardiology Update:  Redefining Efficacy for PCI and Management of Acute Coronary Syndromes—From Initial Presentation to the Cardiac Catheterization Laboratory; Program Chairman, Deepak L. Bhatt, MD, FACC, FSCAI, FESC, FACP

wc Prevention and Management of Venous Thromboembolism —From Landmark Evidence to Optimal Clinical Practice; Program Chairman: Samuel Z. Goldhaber, MD

MedicineWRAPs—A Leading Investigator, First Person Clinical Report

mm AntiplateletWRAP: A leading Investigator, First Person Clinical Report. Presenter: Deepak L. Bhatt, MD. Focus on Oral Antiplatelet Therapy and PPIs in the Setting of ACS and CAD.

mm CardioContrastWRAP—A Leading Investigator, First Person Clinical Report. The Role of Ionic, Low Osmolar Contrast Media for Thrombosis Reduction In the Setting of PCI. Presenter: Steven V. Manoukian, MD.

mm VTECancerWRAP—A Leading Investigator, First Person Clinical Report. Optimizing Management of VTE in Cancer Patients. Presenter: Craig Kessler, MD, MACP

mm DVT-WRAP—A Leading Investigator, First Person Clinical Report.
Part 1: DVT Risk Assessment and Intervention Upon Hospital Admission
Samuel Z. Goldhaber, MD.

mm DVT-WRAP—A Leading Investigator, First Person Clinical Report.
Part 2: Dynamic DVT Risk Assessment During Hospital Admission— Focus on Prophylaxis Triggers and Optimal Use of LMWHs
Samuel Z. Goldhaber, MD.

mm DVT-WRAP—A Leading Investigator, First Person Clinical Report.
Part 3: LMWH-based Therapy in the Post-Hospitalization Phase— Discharge to Home and Skilled Nursing Facilities
Samuel Z. Goldhaber, MD.

mm AntiplateletWRAP—A Leading Investigator, First Person Clinical Report. Antiplateley Therapy in ACS and CABG Surgery. Presenter: Sunil Rao, MD, FACC.

mm STEMI-WRAP—A Leading Investigator, First Person Clinical Report: The Landmark HORIZONS AMI Trial. Gregg Stone, MD, FACC.

mm STEMI-WRAP—A Leading Investigator, First Person Clinical Report: Focus on Oral Antiplatelet Therapy—The Emergency Medicine Perspective   Charles V. Pollack, MD, FACEP.

mm ACS-WRAP—A Leading Investigator, First Person Clinical Report: Applying Evidence to Patient Management. Harold Dauerman, MD, FACC.

mm ACS-WRAP—A Leading Investigator, First Person Report: The Science and Medicine of Acute Coronary Syndrome— Focus on Oral Antiplatelet Therapy in ACS
Presenter: Charles V. Pollack, MD, FACEP

mm Beta-BlockerWRAP—Innovations in Beta-Blocker Therapy for Hypertension: Nitric Oxide, Hemodynamic Profiles,
and Effects on Vascular Endothelium: Presenter: William H. Frishman, MD.

mm Beta-BlockerWRAP—Hypertension in African Americans: Focus on Cardioselective Beta-Blockers. Presenter: Kenneth Jamerson, MD

mm ACS-WRAP—Invasive Management of ACS: Optimal Strategies and Outcomes;
Presenter: Gregg Stone, MD, FACC

mm HypertensionWRAP—A Leading Investigator, First Person Clinical Report: A Treatment Landscape Update and Focus on Cardioselective Beta-Blockers; Michael Weber, MD 

mm HeartWRAP—A Leading Investigator, First Person Clinical Report: Advances in Hypertension and Heart Failure— Foundation Role of Beta-Blockers; Mark Dunlap, MD  

mm ACS-WRAP—A Leading Investigator, First Person Clinical Report: Critical Challenges in Management of Acute Coronary Syndromes; Charles V. Pollack, MA, MD, FACEP, FAAEM

mm PCI-WRAP— A Leading Investigator, First Person Clinical Report: Redefining the Outcome Equation for PCI—Accounting for Ischemic, Thrombosis, and Bleeding End Points; A. Michael Lincoff, MD, FACC

CME-Certified SlideCASTs

mm Focus on ACS: National Experts’ Educational Forum on Acute Cardiovascular Disease: Applying Landmark Trials and Academic Scholarship to the Development of a CME Curriculum for ACS

mmBleeding in the Setting of Acute Coronary Syndromes (ACS): Clinical Implications and Effects on Mortality and Resource Utilization

mmEDICT for ACS: Year 2007 Update—Critical Challenges in Cardiovascular Medicine Advancing Management of Acute Coronary Syndromes (ACS)—Establishing Interventional Cardiology & Emergency Medicine Therapeutic Teams

Primary Care Medicine

logo

wc Optimizing Cardiovascular Outcomes in Type 2 Diabetes.
Program Chairs: Vivian A. Fonseca, MD and A. Michael Lincoff, MD.

National Congress JUST LAUNCHED

wc Kidney-Mediated Glucose Homeostasis in Type 2 Diabetes. Program Chairman: Lawrence Leiter, MD. National Congress

wc Cardiovascular Risk Reduction in Patients with Type 2 Diabetes. Program Chairman: A. Michael Lincoff, MD. National Congress

wc Best Practice Guidelines for Insulin Use in Type 2 Diabetes. Program Chairman: Charles F. Schaefer, MD.

wc Insulin Therapy in Type 2 Diabetes. Program Presenter: Juan P. Frias, MD.

wc Optimizing Outcomes in Type 2 Diabetes. Program Chairman: Vivian A. Fonseca, MD.

wc iQ&A interactive Medical Intelligence Zone for Familial Hypercholesterolemia

wc Optimizing Outcomes in Type 2 Diabetes. Program Chairman: Vivian A. Fonseca, MD. National Congress >

wc New Frontiers and Emerging Paradigms for Cardiovascular Risk Reduction in the Setting of Diabetes and ACS. Program Chairman:
A. Michael Lincoff, MD

National Congress

wc Landmark Practice Advances and New Dimensions on Osteoporosis Management.
Chairman: Mone Zaidi, MD.

wc New Frontiers in the Science and Medicine of Osteoporosis. Program Chairman: Mone Zaidi, MD.

wc The Emerging Challenges on the Therapeutic Landscape of Multiple Sclerosis:The Managed Care Perspective—New York, NY. Program Chairman: Bruce Cree, MD.

wc The Evolving and Complex Therapeutic Landscape for Multiple Sclerosis. Program Chairman: Douglas Jeffery, MD. Atlanta, GA.

wc The Science and Medicine of Hypoactive Sexual Desire Disorder (HSDD).
Program Chair: Anita H. Clayton, MD.

National Congress

wc New Frontiers and Real World Challenges in Osteoporosis.
Program Chair: Mone Zaidi, MD.

wc Under primary care and Neuropsych.
Optimizing Neurotherapy for Multiple Sclerosis and Parkinson’s Disease
Program Chair: C. Warren Olanow, MD.

wc iQ&A interactive Medical Intelligence Zone for Adolescent Depression.
International Experts’ Forum.

wc Osteoporosis Management: Landmark Practice Advances in Patient Assessment, Risk Stratification, and Fracture Reduction. Program Chairman: Mone Zaidi, MD, PhD, FRCP.
National Congress

wc The Science and Medicine of Parkinson’s Disease.Program Chairman: Robert A. Hauser, MD

wc The Science and Medicine of Multiple Sclerosis.Program Chairman: Jerry S. Wolinsky, MD.

wc Optimal Strategies for Compre-hensive Target Organ Protection in Heart Disease and ypertension. Program Chairman: Matthew R. Weir, MD.
National Congress

wc Evolving Perspectives on the Role of Beta-Blockers Acros the Risk Spectrum for Heart Disease.
Program Chairman: Henry R. Black, MD.
National Congress

wc Landmark Advances and New Dimensions In Osteoporosis Research. Program Chairman: Mone Zaidi, MD, PhD, FRCP, FACP National Congress

wc The Science and Medicine of Comprehensive Osteoporosis Management.  Program Chairman: Mone Zaidi, MD, PhD, FRCP, FACP

wc New Dimensions and Landmark Practice Advances In Hypertension and Heart Disease. Program Chairman: Kenneth Jamerson, MD.

wc DiabetesWRAP: Focus on 1,5-Anhydroglucitol (AG) for Monitoring
and Clinical Management of Patients with Diabetes. Presenter: Steven D. Wittlin, MD

wc The Science and Medicine of Parkinson’s Disease. Program Chairman: Lawrence W. Elmer, MD, PhD.  

wc From Threat to Therapy: Vascular Dysfunction And Acute Pressure Syndrome. Program Chairman:
Joseph Varon, MD.

wc Comprehensive Cardiovascular Protection— New Dimensions and Landmark Practice Advances
Program Chairman: Matthew R. Weir, MD.
National Congress

wc Critical Challenges and Landmark Advances in Osteoporosis Research. Program Chairman: Clifford J. Rosen, MD.National Congress

wc Optimizing Management of Hypertension and Cardiovascular Outcomes in the Black Patient—A Year 2007 ISHIB Satellite Symposium  Distinguished Faculty: Shawna Nesbitt, MD, Kenneth Jamerson, MD, Jackson Wright, MD, PhD
National Congress

wc B1 Cardioselective Beta-Blockers— Current Thinking About Conventional vs. Emerging Agents: When? Why? In What Patients? Presenter: Michael Weber, MD

wc Critical Challenges in Neuropsychiatric Health: Depression, Anxiety and Dementia;
Program Chairman: Mark Pollack, MD
 

wc Critical Challenges in Urinary Tract Health: Evidence-Based Strategies for Optimizing Patient Satisfaction and Clinical Outcomes; Program Chairman, David R. Staskin, MD

wc Improving Outcomes in Cardiovascular Disease: Translating Science into Advances for Patient Care: Program Chairman: Michael Weber, MD  

wc Critical Challenges in Alzheimer’s Dementia: A Global Approach for Optimizing Patient Care; Program Chairman, Steven G. Potkin, MD

wc Optimizing Management of Outpatient Infections: Appropriateness of Antibiotic Therapy for Common Respiratory Conditions; Program Chairman, Gregory A. Volturo, MD

wc Overactive Bladder (OAB): From Symptoms to Syndrome—A National Experts’ Perspective; Program Chairman: David R. Staskin, MD

wc Prevention and Management of Venous Thromboembolism —From Landmark Evidence to Optimal Clinical Practice; Program Chairman: Samuel Z. Goldhaber, MD

wc Heart Disease and Stroke: Applying Evidence to the Front Lines of Practice: Focus on Lipid-Lowering Agents Across the Cardiovascular Disease and Stroke Risk Spectrum; Program Chairman: Paul M. Ridker, MD

wc Challenges in Osteoporosis: Optimizing Patient Outcomes—The Primary Care Perspective; Program Chairman, Charles H. Chesnut III, MD

wc A MRSA Infection Update: Optimizing Identification and Risk-Directed Management of Patients With Suspected or Confirmed MRSA Infection’ Program Faculty: Gregory A. Volturo , MD, FACEP, John G. Gums , Pharm. D., Dennis L. Stevens , MD, Pharm. D.

MedicineWRAPs—A Leading Investigator, First Person Clinical Report

mm Alzheimer’sWRAP: A Leading Investigator, First Person Clinical Report. The Foundation Role of Cholinergic Dysregulation in AD
Presenter: Jeffrey L. Cummings, MD

mm OvarianCancerWRAP—A Leading Investigator, First Person Clinical Report: Prenatal Improving Diagnosis and Referral of Women with Ovarian Cancer. Presenter: Fred R. Ueland, MD.

mm GeneticScreeningWRAP—A Leading Investigator, First Person Clinical Report: Prenatal Screening for Genetic Disorders. Presenter: Wayne W. Grody, MD, PhD.

mm MultipleSclerosisWRAP—A Leading Investigator, First Person Clinical Report. Optimizing Clinical Outcomes in MS. Presenter: Patricia Coyle, MD.

mm VitaminD-WRAP: Diagnostic Laboratory Testing for Vitamin D Deficiency Presenter: Michael Holick, PhD, MD.

mm MultipleSclerosisWRAP—Focus on Disease Classification, Natural History and Long-Term Outcomes.
Presenter: Jerry S. Wolinsky, MD.

mm OsteoporosisWRAP—A Leading Investigator, First Person Clinical Report. Optimizing Therapy for Osteoporosis. Felicia Cosman, MD.

mm FibromyalgiaWRAP: Focus on Diagnosis, Assessment, and Pharmacologic Management. Presenter: Don L. Goldenberg, MD.

mm OsteoporosisWRAP—A Leading Investigator, First Person Clinical Report: Landmark Advances in Osteoporosis Management: Optimizing Fracture Reduction at the Front Lines of Patient Care. Felicia Cosman, MD

mm OAB-WRAP—A Leading Investigator, First Person Clinical Report: Focus on Early, Evidence-Based Management of OAB. Presenter: David Staskin, MD.

mm STI-WRAP: Screening and Diagnosis of Sexually Transmitted Infections;Presenter: Glenn M. Preminger, MD.

mm FibromyalgiaWRAP—Optimizing Management of Fibromyalgia: A Systematic Approach to Pharmacotherapy. Presenter: Robert Bennett, MD.

mm Beta-BlockerWRAP—Hypertension in African Americans: Focus on Cardioselective Beta-Blockers. Presenter: Kenneth Jamerson, MD

mm OsteoporosisWRAP: A Leading Investigator, First Person, Clinical Report - Annual Cumulative Exposure (ACE) of Bisphosphonates: Relationship to Bone Mineral Density (BMD) and Fracture Reduction. Presenter: Mone Zaidi, MD, PhD, FRCP

mm PsychiatryWRAP: Screen and Intervene—Critical Challenges in Alzheimer's Dementia; Presenter, George T. Grossberg, MD

mm HypertensionWRAP—A Leading Investigator, First Person Clinical Report: A Treatment Landscape Update and Focus on Cardioselective Beta-Blockers; Michael Weber, MD

mm OAB-WRAP: A Leading Investigator, First Person Clinical Report. Clinical Challenges And Optimizing Patient Outcomes in Overactive Bladder; National Expert Presenter: Scott MacDiarmid MD

mm Alzheimer’sWRAP: Diagnosis, Staging, and Outcome-Effective Drug Therapy: An Evidence-Based Perspective; Presenter, Jeffrey L. Cummings, MD

mm MRSA-WRAP—A Leading Investigator, First Person Clinical Report: Critical Challenges in MRSA Skin and Skin Structure Infections: Presenter, Lena M. Napolitano MD, FACS, FCCP, FCCM

mm OsteoporosisWRAP: A Leading Investigator, First Person, Clinical Report—Screen And Intervene: Clinical Challenges In Osteoporosis Management; Program Chairman, Mone Zaidi, MD, PhD, FRCP

Hypertension

wc Landmark Advances and Complex Cases in Cardiovascular Anesthesi-ology. Program Chairmen: Solomon Aronson, MD and Jerrold Levy, MD.National Congress

wc Optimal Strategies for Compre-hensive Target Organ Protection in Heart Disease and ypertension. Program Chairman: Matthew R. Weir, MD.
National Congress

wc Evolving Perspectives on the Role of Beta-Blockers Acros the Risk Spectrum for Heart Disease.
Program Chairman: Henry R. Black, MD.
National Congress

wc Landmark Practice Advances in Acute Blood Pressure Management.Program Chairman: Charles V. Pollack, MD, FACEP. National Congress

wc New Dimensions and Landmark Practice Advances In Hypertension and Heart Disease. Program Chairman: Kenneth Jamerson, MD.

wc Landmark Advances in Cardiovascular Anesthesiology. Program Chairmen: Jerrold H. Levy, MD and Solomon Aronson, MD

wc The Science and Medicine of Circulatory Dysfunction and Acute Pressure Syndromes. Program Chairman: Christopher B. Granger, MD

wc From Threat to Therapy: Vascular Dysfunction And Acute Pressure Syndrome. Program Chairman:
Joseph Varon, MD.

wc Vascular Dysfunction and Acute Pressure Syndromes. Program Chairman: Christopher B. Granger, MD
National Congress

wc Comprehensive Cardiovascular Protection— New Dimensions and Landmark Practice Advances
Program Chairman: Matthew R. Weir, MD.
National Congress

wc Acute Pressure Syndromes—From Threat to Therapy. Program Chairman: Charles V. Pollack, MD, FACEP  
National Congress

wc Cardiovascular Emergencies—New Dimensions and Critical Practice Advances Program Chairman: Charles V. Pollack, MD, FACEP 
National Congress

wc Optimizing Management of Hypertension and Cardiovascular Outcomes in the Black Patient—A Year 2007 ISHIB Satellite Symposium  Distinguished Faculty: Shawna Nesbitt, MD, Kenneth Jamerson, MD, Jackson Wright, MD, PhD
National Congress

wc B1 Cardioselective Beta-Blockers— Current Thinking About Conventional vs. Emerging Agents: When? Why? In What Patients? Presenter: Michael Weber, MD

wc Acute Blood Pressure Elevation in the Perioperative Setting: Issues, Challenges, and Options: A Sanctioned CME Satellite at the Society for Cardiovascular Anesthesiology; Faculty: Solomon Aronson, MD, FACC and Jerrold Levy, MD (Co-Chairmen) and Kevin Stierer, MD.
| National Congress

mm Beta-BlockerWRAP—Innovations in Beta-Blocker Therapy for Hypertension: Nitric Oxide, Hemodynamic Profiles,
and Effects on Vascular Endothelium: Presenter: William H. Frishman, MD.

mm Beta-BlockerWRAP—Hypertension in African Americans: Focus on Cardioselective Beta-Blockers. Presenter: Kenneth Jamerson, MD

mm Advances in Hypertension and Global Risk Management: Translating Science into Clinical Practice: Program Faculty: Henry Black, MD, Elijah Saunders, MD, FACC, FACP, Michael Weber, MD

mm HypertensionWRAP—A Leading Investigator, First Person Clinical Report: A Treatment Landscape Update and Focus on Cardioselective Beta-Blockers; Michael Weber, MD  

mm CardiologyWRAP—A Leading Investigator, First Person Clinical Report: Advances in Hypertension and Heart Failure— Foundation Role of Beta-Blockers; Mark Dunlap, MD

wc What’s New in Hypertension?—The Current Role of Beta-Blockers; Program Chairman: Mark Dunlap, MD  

wc Heart Disease and Stroke: Applying Evidence to the Front Lines of Practice: Focus on Hypertension and Lipid-Lowering Agents Across the Cardiovascular Disease and Stroke Risk Spectrum; Program Chairman: Paul M. Ridker, MD

Infectious Diseases

logo

wc Optimizing Sepsis Management.
Program Chair: Ronald J. DeBellis, PharmD, FCCP.
 National Congress.

wc The Multifaceted Frontiers of Sepsis Research and Management.
Program Chairs: Douglas Golenbock, MD and Stephen Opal, MD.

International Congress.

wc The Science and Management of Sepsis. Program Chairman: Gregory A. Volturo, MD, FACEP.
National Congress.

wc New Perspectives in Sepsis for the Critical Care Nurse. Program Chair: Ruth M. Kleinpell, PhD, RN.
National Congress

wc Optimizing Management of Outpatient Infections: Appropriateness of Antibiotic Therapy for Common Respiratory Conditions; Program Chairman, Gregory A. Volturo, MD

wc The Emerging MRSA Crisis in Hospital Medicine—Data, Diagnosis, and Delivering Care; Program Faculty: Keith Beck , MD, Gregory Moran , MD, Gregory A. Volturo, MD

wc A MRSA Infection Update: Optimizing Identification and Risk-Directed Management of Patients With Suspected or Confirmed MRSA Infection’ Program Faculty: Gregory A. Volturo , MD, FACEP, John G. Gums , Pharm. D., Dennis L. Stevens , MD, Pharm. D.

MedicineWRAPs—A Leading Investigator, First Person Clinical Report

mm STI-WRAP: Screening and Diagnosis of Sexually Transmitted Infections;
Presenter: Glenn M. Preminger, MD
.

mm MRSA-WRAP—A Leading Investigator, First Person Clinical Report: Critical Challenges in MRSA Skin and Skin Structure Infections: Presenter, Lena M. Napolitano MD, FACS, FCCP, FCCM

mm PulmonaryMedicineWRAP: MRSA Lung Infection—Meeting the Diagnostic and Therapeutic Challenges: From the Community to the Hospital Setting; Presenter, Marin H. Kollef, MD

Clinical Consensus Updates

pubClinical Consensus Updates in Infectious Diseases: The Evolving Challenges of MRSA Infection—From the Hospital to the Community: Optimizing Prevention, Detection, and Antimicrobial Therapy of MRSA Pulmonary, Skin, & Soft Tissue Infections; A National Expert’s Consensus Statement

pubClinical Consensus Updates in Gastroenterology: The Complex Clinical Challenges Presented by Patients with HIV-HCV Coinfection; A National Experts’ Consensus Report

Bone Disease—Osteoporosis

Orthopedics, and

Osteoinflammatory Disorders

wc Landmark Practice Advances and New Dimensions on Osteoporosis Management.
Chairman: Mone Zaidi, MD.

wc New Frontiers in the Science and Medicine of Osteoporosis. Program Chairman: Mone Zaidi, MD.

wc New Frontiers and Real World Challenges in Osteoporosis.
Program Chair: Mone Zaidi, MD.

wc Osteoporosis Management: Landmark Practice Advances in Patient Assessment, Risk Stratification, and Fracture Reduction. Program Chairman: Mone Zaidi, MD, PhD, FRCP.
National Congress

wc Landmark Advances and New Dimensions In Osteoporosis Research. Program Chairman: Mone Zaidi, MD, PhD, FRCP, FACP National Congress

wc The Science and Medicine of Comprehensive Osteoporosis Management.   Program Chairman: Mone Zaidi, MD, PhD, FRCP, FACP

wc The Science and Medicine of Comprehensive Osteoporosis Management. Program Chair: Mone Zaidi, MD, PhD, FRCP
National Congress

wc Critical Challenges and Landmark Advances in Osteoporosis Research. Program Chairman: Clifford J. Rosen, MD.National Congress

wc Challenges in Osteoporosis: Optimizing Patient Outcomes—The Primary Care Perspective; Program Chairman, Charles H. Chesnut III, MD

wc Diagnosis, Monitoring and Management of Osteoporosis: Applying Landmark Evidence, Clinical Trial Results, and National Guidelines to the Front Lines of Clinical Practice; Program Chairman, Michael J. Maricic, MD

wc Critical Challenges in Orthopedic Surgery: A Science-to-Strategy CME Clinical Excellence Summit Focused on DVT Prophylaxis in High Risk Patients; Program Chairman, Javad Parvizi, MD, FRCS  National Congress

wc Screen and Intervene—Meeting the Challenge of Osteoporosis: Focus on Diagnosis, Treatment Triggers, and Pharmacologic Therapy; Program Chairman; Mone Zaidi, MD, PhD, FRCP

MedicineWRAPs—A Leading Investigator, First Person Clinical Report

mm OsteoporosisWRAP—A Leading Investigator, First Person Clinical Report. Optimizing Outcomes with Evidence-Based Approaches for Bisphosphonate Therapy
Sol Epstein, MD
.

mm OsteoporosisWRAP—A Leading Investigator, First Person Clinical Report. Optimizing Fracture Reduction in Osteoporosis. Steven Harris, MD, FACP.

mm OsteoporosisWRAP—A Leading Investigator, First Person Clinical Report. Optimizing Therapy for Osteoporosis. Felicia Cosman, MD.

mm OsteoporosisWRAP—A Leading Investigator, First Person Clinical Report: Landmark Advances in Osteoporosis Management: Optimizing Fracture Reduction at the Front Lines of Patient Care. Felicia Cosman, MD

mm OsteoporosisWRAP: A Leading Investigator, First Person, Clinical Report - Annual Cumulative Exposure (ACE) of Bisphosphonates: Relationship to Bone Mineral Density (BMD) and Fracture Reduction. Presenter: Mone Zaidi, MD, PhD, FRCP

mm OsteoporosisWRAP: A Leading Investigator, First Person, Clinical Report—Screen And Intervene: Clinical Challenges In Osteoporosis Management; Program Chairman, Mone Zaidi, MD, PhD, FRCP

Critical Care/

Emergency Medicine

logo

wc Optimizing Sepsis Management.
Program Chair: Ronald J. DeBellis, PharmD, FCCP.
 National Congress.

wc The Multifaceted Frontiers of Sepsis Research and Management.
Program Chairs: Douglas Golenbock, MD and Stephen Opal, MD.

International Congress.

wc New Frontiers in Stroke Prevention for Atrial Fibrillation.
Program Chairman: Allan V. Abbott, MD.

National Congress.

wc The Science and Management of Sepsis. Program Chairman: Gregory A. Volturo, MD, FACEP.
National Congress.

wc New Perspectives in Sepsis for the Critical Care Nurse. Program Chair: Ruth M. Kleinpell, PhD, RN.
National Congress

wc New Frontiers in Thrombosis Reduction for Heart Disease.
Program Chairman Deepak L. Bhatt, MD.
 International Congress

wc New Frontiers in the Science and Medicine of Venous Thromboembolism.
Program Chair: Samuel Z. Goldhaber, MD.
 International Congress

wc Sepsis Research—The Critical Care Perspective.  Program Chairman: Mitchell P. Fink, MD.
National Congress

wc The New Frontiers in Atrial Fibrillation  .Program Chairman: Samuel Z. Goldhaber, MD National Congress

wc Critical Advances in the Evolving Science and Medicine of STEMI Management and High-Risk ACS Program Chairman: Sunil V. Rao.National Congress

wc Optimizing Outcomes in Patients
with STEMI and High-Risk ACS.
Rome, Italy.
International Congress

wc Management of STEMI and High Risk ACS. Program Chairman: Sunil V. Rao, MD National Congress

wc European Cardiovascular Experts’ STEMI (ECES) Summit. Zurich, Switzerland. International Summit

wc Landmark Advances in High Risk Acute Coronary Syndrome Program Chairman: Charles V. Pollack, MD, FACEP.National Congress

wc Landmark Practice Advances in Acute Blood Pressure Management.Program Chairman: Charles V. Pollack, MD, FACEP. National Congress

wc Landmark Advances in Cardiovascular Anesthesiology. Program Chairmen: Jerrold H. Levy, MD and Solomon Aronson, MD

wc Milestone Practice Advances in
STEMI and High Risk ACS.
Program Chairman: Sunil Rao, MD

wc The Science and Medicine of Acute Coronary Syndrome. Program Chairman: Sunil V. Rao, MD
| National Congress

wc The Science and Medicine of Circulatory Dysfunction and Acute Pressure Syndromes. Program Chairman: Christopher B. Granger, MD

wc Critical Challenges and Landmark Advances in Vascular Interventional Management. Program Chairman: Deepak Bhatt, MD, FACC, FSCAI, FESC, FACP National Congress

wc Critical Challenges in Acute Coronary Syndromes—The Road from REPLACE-2 to ACUITY and HORIZONS MI.   Program Chairman: E. Magnus Ohman, MD, FRCPI, FACC.National Congress

wc Vascular Dysfunction and Acute Pressure Syndromes. Program Chairman: Christopher B. Granger, MD
National Congress

wc Cardiovascular Emergencies—New Dimensions and Critical Practice Advances Program Chairman: Charles V. Pollack, MD, FACEP National Congress

wc Evolving Approaches to Antithrombotic Therapy in Patients with Acute Ischemic Heart Disease-Establishing Evidence-and Collaboration-Based ACS Management Protocols for Interventional Cardiologists and Emergency Medicine Specialists: A National and Regional EDICT for ACS Initiative, New York; Program Chairmen, Gregg Stone, MD, FACC and Charles V. Pollack, MD, FACEP  

wc Advancing The Management of Acute Coronary Syndromes (ACS)—The Emergency Medicine Perspective; Program Chairman: Charles V. Pollack, MA, MD, FACEP, FAAEM  National Congress

wc Critical Challenges in Cardiovascular Medicine: Establishing Interventional Cardiology and Emergency Medicine Therapeutic Teams (EDICT) for ACS; Program Chairman: Steven V. Manoukian, MD, FACC  

wc Hot Cases in ACS: Managing Patients with High Risk Acute Coronary Syndromes—National Experts Weigh in on Strategies and the Evidence; Program Chairman, A. Michael Lincoff, MD; Panel Members: Elliott Antmann, MD, Peter Berger, MD, Magnus Ohman, MD   National Congress

wc EDICT (Emergency Department and Interventional Cardiology Therapeutic teams) for ACS: Critical Challenges in Cardiovascular Medicine—Establishing Seamless Interventional Cardiology and Emergency Medicine Clinical Strategies ; 2007, Boston, MA., Program Chairmen: Michael Gibson, MD and Charles Pollack, MD.  

wc Optimizing Management of Outpatient Infections: Appropriateness of Antibiotic Therapy for Common Respiratory Conditions; Program Chairman, Gregory A. Volturo, MD

wc The Emerging MRSA Crisis in Hospital Medicine—Data, Diagnosis, and Delivering Care; Program Faculty: Keith Beck , MD, Gregory Moran , MD, Gregory A. Volturo, MD

MedicineWRAPs—A Leading Investigator, First Person Clinical Report

mm AntiplateletWRAP: A leading Investigator, First Person Clinical Report. Presenter: Deepak L. Bhatt, MD. Focus on Oral Antiplatelet Therapy and PPIs in the Setting of ACS and CAD.

mm DVT-WRAP—A Leading Investigator, First Person Clinical Report.
Part 1: DVT Risk Assessment and Intervention Upon Hospital Admission
Samuel Z. Goldhaber, MD.

mm DVT-WRAP—A Leading Investigator, First Person Clinical Report.
Part 2: Dynamic DVT Risk Assessment During Hospital Admission— Focus on Prophylaxis Triggers and Optimal Use of LMWHs
Samuel Z. Goldhaber, MD.

mm DVT-WRAP—A Leading Investigator, First Person Clinical Report.
Part 3: LMWH-based Therapy in the Post-Hospitalization Phase— Discharge to Home and Skilled Nursing Facilities
Samuel Z. Goldhaber, MD.

mm AntiplateletWRAP—A Leading Investigator, First Person Clinical Report. Antiplateley Therapy in ACS and CABG Surgery. Presenter: Sunil Rao, MD, FACC.

mm STEMI-WRAP—A Leading Investigator, First Person Clinical Report: The Landmark HORIZONS AMI Trial. Gregg Stone, MD, FACC.

mm STEMI-WRAP—A Leading Investigator, First Person Clinical Report: Focus on Oral Antiplatelet Therapy—The Emergency Medicine Perspective   Charles V. Pollack, MD, FACEP.

mm ACS-WRAP—A Leading Investigator, First Person Clinical Report: Applying Evidence to Patient Management. Harold Dauerman, MD, FACC.

mm ACS-WRAP—A Leading Investigator, First Person Report: The Science and Medicine of Acute Coronary Syndrome— Focus on Oral Antiplatelet Therapy in ACS
Presenter: Charles V. Pollack, MD, FACEP

mm ACS-WRAP—Invasive Management of ACS: Optimal Strategies and Outcomes; Presenter: Gregg Stone, MD, FACC

mm ACS-WRAP—A Leading Investigator, First Person Clinical Report: Critical Challenges in Management of Acute Coronary Syndromes; Charles V. Pollack, MA, MD, FACEP, FAAEM

mm PCI-WRAP— A Leading Investigator, First Person Clinical Report: Redefining the Outcome Equation for PCI—Accounting for Ischemic, Thrombosis, and Bleeding End Points; A. Michael Lincoff, MD, FACC

mm MRSA-WRAP—A Leading Investigator, First Person Clinical Report: Critical Challenges in MRSA Skin and Skin Structure Infections: Presenter, Lena M. Napolitano MD, FACS, FCCP, FCCM

CME-Certified SlideCASTs

mm Focus on ACS: National Experts’ Educational Forum on Acute Cardiovascular Disease: Applying Landmark Trials and Academic Scholarship to the Development of a CME Curriculum for ACS

mm Bleeding in the Setting of Acute Coronary Syndromes (ACS): Clinical Implications and Effects on Mortality and Resource Utilization

mm EDICT for ACS: Year 2007 Update—Critical Challenges in Cardiovascular Medicine Advancing Management of Acute Coronary Syndromes (ACS)—Establishing Interventional Cardiology & Emergency Medicine Therapeutic Teams

Clinical Consensus Updates

pubClinical Consensus Updates in Infectious Diseases: The Evolving Challenges of MRSA Infection—From the Hospital to the Community: Optimizing Prevention, Detection, and Antimicrobial Therapy of MRSA Pulmonary, Skin, & Soft Tissue Infections; A National Expert’s Consensus Statement

pubClinical Consensus Updates in Gastroenterology: The Complex Clinical Challenges Presented by Patients with HIV-HCV Coinfection; A National Experts’ Consensus Report

Thrombosis

logo

wc Stroke Prevention in Atrial Fibrillation. Program Chair:
Samuel Z. Goldhaber, MD.

National Congress

wc The Science and Application of Antithrombotic Interventions for High Risk ACS. Program Chairman:
Deepak L. Bhatt, MD.

National Congress

wc New Frontiers and Evolving Paradigms in Cancer and Thrombosis. Program Chairman: Professor the Lord Ajay Kakkar, (HONS) BSC, PhD, FRCS.
International Congress

wc Lake Breaking Advances in Stroke Prevention in Atrial Fibrillation. Program Chairman:
Samuel Z. Goldhaber, MD.

wc New Frontiers in Stroke Prevention in Atrial Fibrillation. Program Chairman:
Samuel Z. Goldhaber, MD.

wc Stroke Prevention in Atrial Fibrillation. Program Chairman:
Samuel Z. Goldhaber, MD.

National Congress.

wc New Frontiers and Evolving Paradigms in Cancer and Thrombosis.
Program Chairman:
Samuel Z. Goldhaber, MD.

National Congress.

wc iQ&A interactive Medical Intelligence Zone for Stroke Prevention in Atrial Fibrillation. Program Chairman: Samuel Z. Goldhaber, MD.

wc New Frontiers in Stroke Prevention for Atrial Fibrillation.
Program Chairman: Allan V. Abbott, MD.

National Congress.

wc iQ&A interactive Medical Intelligence Zone for VTE Prophylaxis.
Program Chairman: Samuel Z. Goldhaber, MD.
 

wc Optimizing Supportive Care in Cancer. Program Chairman: Gary H. Lyman, MD.  International Congress

wc New Frontiers in Thrombosis Reduction for Heart Disease.
Program Chairman Deepak L. Bhatt, MD.
 International Congress

wc New Frontiers in the Science and Medicine of Venous Thromboembolism.
Program Chair: Samuel Z. Goldhaber, MD.
 International Congress

wc New Paradigms and Landscape Changes in Atrial Fibrillation.   Program Chairman: Peter Libby, MD, FACC.
National Congress

wc The iQ&A interactive Medical Intelligence Zone for Thrombosis Management.Program Chairman: Samuel Z. Goldhaber, MD

wc The iQ&A interactive Medical Intelligence Zone for DVT and PE.
Program Chairman: Samuel Z. Goldhaber, MD

wc The New Frontiers in Atrial Fibrillation  .Program Chairman: Samuel Z. Goldhaber, MD
National Congress

wc The Evolving Science and Medicine of Myelodysplastic Syndromes. Program Chair: Frederick Appelbaum, MD.National Congress

wc The Science and Medicine of Cancer and Thrombosis Management.
Program Chair: Craig M. Kessler, MD.

International Congress

wc Supportive Care for the Cancer Patient. Program Chairmen: Craig M. Kessler, MD and Steven Grunberg, MD

wc DVT Prophylaxis in the Cancer Patient. Program Co-Chairs: Edith Nutescu, PharmD, FCCP, and Samuel Z. Goldhaber, MD.
National Congress

wc VTE Prophylaxis in the Setting of Cancer.Program Chairman: Craig M. Kessler, MD.

wc Cancer and Thrombosis Management.   Program Chairman: Charles W. Francis, MD
National Congress

wc Critical Challenges and Landmark Advances in Venous Thromboembolism.   Program Chairman: Ajay Kakkar, MBBS, PhD, FRCS.   International Congress

wc Cancer, Clotting and Controversies— Critical Challenges and Landmark Advances in Venous Thrombosis. Program Chairman: Craig M. Kessler, MD.   National Congress

wc Evolving Approaches to Antithrombotic Therapy in Patients with Acute Ischemic Heart Disease-Establishing Evidence-and Collaboration-Based ACS Management Protocols for Interventional Cardiologists and Emergency Medicine Specialists: A National and Regional EDICT for ACS Initiative, New York; Program Chairmen, Gregg Stone, MD, FACC and Charles V. Pollack, MD, FACEP  

wc Critical Challenges in Cardiovascular Medicine: Establishing Interventional Cardiology and Emergency Medicine Therapeutic Teams (EDICT) for ACS; Program Chairman: Steven V. Manoukian, MD, FACC  

wc Optimizing Clinical Strategies in Heart Disease: Linking Science and Expert Analysis to Advances in Hypertension— Focus on Cardioselective Beta-Blockers and Risk Factor Management; Program Chairman: Michael Weber, MD

wc Advancing Management of Acute Coronary Syndromes—A National Experts’ Science-to-Strategy Summit and Satellite Symposium; Program Chairman: Peter B. Berger, MD, FACC   | National Congress

wc Hot Cases in ACS: Managing Patients with High Risk Acute Coronary Syndromes—National Experts Weigh in on Strategies and the Evidence; Program Chairman, A. Michael Lincoff, MD; Panel Members: Elliott Antmann, MD, Peter Berger, MD, Magnus Ohman, MD National Congress

wc EDICT (Emergency Department and Interventional Cardiology Therapeutic teams) for ACS: Critical Challenges in Cardiovascular Medicine—Establishing Seamless Interventional Cardiology and Emergency Medicine Clinical Strategies ; 2007, Boston, MA., Program Chairmen: Michael Gibson, MD and Charles Pollack, MD.

wc Advances in Hypertension, Heart Failure, and Global Risk Management in Heart Disease—The Current Role of Beta-Blockers; Program Chairman: Mark Dunlap, MD  

wc Heart Disease and Stroke: Applying Evidence to the Front Lines of Practice: Focus on Lipid-Lowering Agents Across the Cardiovascular Disease and Stroke Risk Spectrum; Program Chairman: Paul M. Ridker, M

wc Advancing The Management of Acute Coronary Syndromes (ACS)—The Emergency Medicine Perspective; Program Chairman: Charles V. Pollack, MA, MD, FACEP, FAAEM  
National Congress

wc Optimizing Net Clinical Benefit in PCI: Applying Late-Breaking, Research in ACS Management to the Cardiac Catheterization Laboratory; Program Chairman: Jeffery J. Popma, MD, FSCAI   National Congress

wc ACS Management in the Emergency Department: Approaches to Dynamic Risk Assessment and Antithrombotic Therapy; Program Chairman: Charles V. Pollack, MA, MD, FACEP, FAAEM   National Congress

wc Interventional Cardiology Update:  Redefining Efficacy for PCI and Management of Acute Coronary Syndromes—From Initial Presentation to the Cardiac Catheterization Laboratory; Program Chairman, Deepak L. Bhatt, MD, FACC, FSCAI, FESC, FACP

wc Prevention and Management of Venous Thromboembolism —From Landmark Evidence to Optimal Clinical Practice; Program Chairman: Samuel Z. Goldhaber, MD

wc Critical Challenges in Orthopedic Surgery: A Science-to-Strategy CME Clinical Excellence Summit Focused on DVT Prophylaxis in High Risk Patients; Program Chairman, Javad Parvizi, MD, FRCS   National Congress

MedicineWRAPs—A Leading Investigator, First Person
Clinical Report

mm AntiplateletWRAP: A leading Investigator, First Person Clinical Report. Presenter: Deepak L. Bhatt, MD. Focus on Oral Antiplatelet Therapy and PPIs in the Setting of ACS and CAD.

mm CardioContrastWRAP—A Leading Investigator, First Person Clinical Report. The Role of Ionic, Low Osmolar Contrast Media for Thrombosis Reduction In the Setting of PCI. Presenter: Steven V. Manoukian, MD.

mm VTECancerWRAP—A Leading Investigator, First Person Clinical Report. Optimizing Management of VTE in Cancer Patients. Presenter: Craig Kessler, MD, MACP

mm DVT-WRAP—A Leading Investigator, First Person Clinical Report.
Part 1: DVT Risk Assessment and Intervention Upon Hospital Admission
Samuel Z. Goldhaber, MD.

mm DVT-WRAP—A Leading Investigator, First Person Clinical Report.
Part 2: Dynamic DVT Risk Assessment During Hospital Admission— Focus on Prophylaxis Triggers and Optimal Use of LMWHs
Samuel Z. Goldhaber, MD.

mm DVT-WRAP—A Leading Investigator, First Person Clinical Report.
Part 3: LMWH-based Therapy in the Post-Hospitalization Phase— Discharge to Home and Skilled Nursing Facilities
Samuel Z. Goldhaber, MD.

mm STEMI-WRAP—A Leading Investigator, First Person Clinical Report: The Landmark HORIZONS AMI Trial. Gregg Stone, MD, FACC.

mm STEMI-WRAP—A Leading Investigator, First Person Clinical Report: Focus on Oral Antiplatelet Therapy—The Emergency Medicine Perspective   Charles V. Pollack, MD, FACEP.

mm ACS-WRAP—Invasive Management of ACS: Optimal Strategies and Outcomes;  Presenter: Gregg Stone, MD, FACC

mm ACS-WRAP—A Leading Investigator, First Person Clinical Report: Critical Challenges in Management of Acute Coronary Syndromes; Charles V. Pollack, MA, MD, FACEP, FAAE

mm PCI-WRAP— A Leading Investigator, First Person Clinical Report: Redefining the Outcome Equation for PCI—Accounting for Ischemic, Thrombosis, and Bleeding End Points; A. Michael Lincoff, MD, FAC

CME-Certified SlideCASTs

mm Focus on ACS: National Experts’ Educational Forum on Acute Cardiovascular Disease: Applying Landmark Trials and Academic Scholarship to the Development of a CME Curriculum for ACS

mm Bleeding in the Setting of Acute Coronary Syndromes (ACS): Clinical Implications and Effects on Mortality and Resource Utilization

mm EDICT for ACS: Year 2007 Update—Critical Challenges in Cardiovascular Medicine Advancing Management of Acute Coronary Syndromes (ACS)—Establishing Interventional Cardiology & Emergency Medicine Therapeutic Team

Surgical Procedures—

OR-Live.com

wc AnesthesiologyWRAP—A Leading Investigator, First Person Clinical Report.
Landmark Advances in Minimal and Moderate Sedation. T.J. Gan, MB, FRCA, MHS, Li. Ac.

wc Laparoscopic Gastric Bypass Surgery
Surgeons at Tufts-New England Medical Center perform the "gold standard" for treating obesity

wc Cesarean Childbirth
Hartford Hospital presents a Cesarean Section delivery

wc Laparoscopic Incisional/Ventral Hernia Repair
See a laparoscopic incisional/ventral hernia repair from the University of Maryland Medical Center.

wc Abdominal Myomectomy—A Treatment for the Removal of Fibroids
Brooklyn's Long Island College Hospital presents an open surgery, Abdominal Myomectomy, to remove uterine fibroids.

wc Brain Tumor Surgery/GliaSite Radiation Therapy
Treatment for recurrent brain tumors from Methodist Hospital in Memphis, TN.

wc Transforaminal Lumbar Interbody Fusion (TLIF) Procedure
Memorial Hermann Hospital, Houston, TX showcases TLIF: a safe, effective surgical option for serve pain.

wc CPAP (Continuous Positive Airway Pressure)
Non-invasive technique for Respiratory Distress Syndrome to prevent Chronic Lung Disease in newborns

wc Birmingham Hip Resurfacing : Alternative to Standard Total Hip Replacement
Wake Forest University Baptist Medical Center surgeons demonstrate a Hip Resurfacing procedure.

wc Improved Surgical Techniques for Prostate Cancer
Brigham and Women's Hospital features improved surgical techniques for prostate cancer. New procedure reduces side effects including incontinence and sexual dysfunction.

CMEducation Specialty Sites

MedicineCAST.net

NeuropsychCAST.net

ClinicalWebcasts.com

Cardiocast.net

OsteoporosisCAST.com

EDICTforACS.com

OneHeartAlliance.com

DiagnosisCAST.com

HypertensionCAST.com

EDICTforPRESSURECONTROL.com

OAB-Online.net